Evidence map›Paper›PMID 40485992›Full record

ArticleAsia-Pacific journal of oncology nursing2025

Initial quality of life and influencing factors in patients with advanced cancer receiving home hospice care: A propensity score-matched analysis stratified by survival period.

Yitao Wei, Huina Zou, Wan Cheng, Hong Wu, Shaowei Lin, Jianwei Zheng, Huimin Xiao

Abstract read
In one paragraph

Article in Asia-Pacific journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yitao WeiSchool of Nursing, Fujian Medical University, Fuzhou, China.
Huina ZouSchool of Nursing, Fujian Medical University, Fuzhou, China.
Wan ChengSchool of Nursing, Fujian Medical University, Fuzhou, China.
Hong WuDepartment of Hospice Care, Fujian Provincial Hospital, Fuzhou, China.
Shaowei LinSchool of Public Health, Fujian Medical University, Fuzhou, China.
Jianwei ZhengDepartment of Oncology, Fujian Medical University Union Hospital, Fuzhou, China.
Huimin XiaoSchool of Nursing, Fujian Medical University, Fuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Quality of life (QoL) is increasingly recognized as an important prognostic indicator and has been identified to be associated with reduced survival in patients with advanced cancer during the last months of life. This study aimed to compare the initial QoL and influencing factors of patients with advanced cancer receiving home hospice care with less than 3-month survival period. Methods: A secondary data analysis study was conducted using the data from a Fujian provincial home hospice center, in China, between 2010 and 2020. Propensity score matching was performed in 2761 cases to match patients with a less than 1 month survival period and those with a 1-3 months survival period. Differences in QoL between the two groups were analyzed using the ANOVA or Wilcoxon Mann-Whitney test, and the influencing factors were analyzed using multiple linear regression analysis. Results: No significant differences in QoL were identified between cancer patients with a 1-3 month survival period and those with a survival period of less than 1 month. However, a significant difference was detected after the propensity score matching adjustment ( Conclusions: The QoL of patients with advanced cancer receiving home hospice care is poor but does not necessarily deteriorate continuously during the last 3 months. Notably, the complexity of factors influencing QoL increases significantly as patients approach death.

Indexed as

Advanced cancerHospice carePropensity score matchingQuality of lifeRetrospective observational cohort

Identifiers

PMID40485992
PMCPMC12143826

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.